U.S. Markets open in 4 hrs 40 mins

  • S&P Futures

    4,297.75
    -10.00 (-0.23%)
     

  • Dow Futures

    34,065.00
    -53.00 (-0.16%)
     

  • Nasdaq Futures

    13,603.50
    -54.75 (-0.40%)
     

  • Russell 2000 Futures

    2,019.50
    -3.80 (-0.19%)
     

  • Crude Oil

    86.64
    +0.11 (+0.13%)
     

  • Gold

    1,788.70
    -1.00 (-0.06%)
     

  • Silver

    20.00
    -0.09 (-0.45%)
     

  • EUR/USD

    1.0168
    -0.0003 (-0.0305%)
     

  • 10-Yr Bond

    2.8240
    0.0000 (0.00%)
     

  • Vix

    19.82
    -0.13 (-0.65%)
     

  • GBP/USD

    1.2096
    +0.0001 (+0.0109%)
     

  • USD/JPY

    134.8020
    +0.5870 (+0.4374%)
     

  • BTC-USD

    23,827.94
    -179.06 (-0.75%)
     

  • CMC Crypto 200

    568.72
    -3.20 (-0.56%)
     

  • FTSE 100

    7,540.93
    +4.87 (+0.06%)
     

  • Nikkei 225

    29,222.77
    +353.86 (+1.23%)
     

Oncocyte Acquires Blood-Based Molecular Diagnostics Provider, Chronix Biomedical For Roughly $10 Million

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • OCX

  • Oncocyte Corporation (NYSE: OCX) has agreed to acquire Chronix Biomedical, a privately held molecular diagnostics company, developing blood tests for cancer treatment and organ transplants. This agreement supersedes the previous agreement announced in October 2020.

  • Under the agreement, Chronix's development and the business team will become part of the Oncocyte R&D team maintaining lab operations in Germany and lead Oncocyte's commercial efforts with DetermaRx and DetermaIO in Germany and other EU member countries.

  • Oncocyte intends to accelerate further development of the CNI test that measures the amount of that copy number variation present in blood that has been shed by dying tumor cells.

  • Oncocyte believes the addition of the CNI test will enable it to enter into blood-based immune-therapy monitoring. The test is expected to be launched in the second half of 2021, only-for research use.

  • Upon closing, Oncocyte will pay $2.675 million in cash, $1.5 million of Oncocyte shares, and assume liabilities not to exceed $5.5 million.

  • The agreement also provides for Oncocyte to pay a revenue share on the net collected revenues for certain tests and services for specific periods and to pay a combination of cash or Oncocyte common stock of up to $14 million if certain milestones are achieved.

  • The transaction is expected to complete by April 30.

  • Price Action: OCX shares are up by 0.20% at $5.10 on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Mr. Big Short Michael Burry Makes a Shocking Decision

    The investor, who successfully bet against the U.S. mortgage market before the 2008 financial crisis, has just made a huge gamble.

  • ZIM Q2 Preview: Can Shares Remain Hot?

    Year-to-date, ZIM shares have been notably strong, increasing by a double-digit 11% in value and extensively outperforming the S&P 500.

  • Billionaire Ray Dalio Loads Up on These 3 “Strong Buy” Stocks

    In the last month, both the S&P and the NASDAQ climbed back out of bear territory, and are registering 10% and 13% gains respectively. It’s enough to make investors' heads spin. Let's not forget, the markets presented investors with a bearish challenge in 1H22, with 6 straight months of losses. Headwinds, in the form of supply chain problems, Russia’s invasion of Ukraine, inflation at generational high levels, rising interest rates, all combined to give investors the shivers. For the retail inve

  • Elon Musk Says He Was Joking About Buying Manchester United. But Tesla Investors Still Have to Care.

    Elon Musk tweeted Tuesday evening that he was buying Manchester United, but later said he was joking. Like it or not, the tweet is another thing for Tesla investors to worry about.

  • 2 ‘Strong Buy’ Stocks Goldman Sachs Predicts Will Surge Over 40%

    The stock market is finding support right now from two directions, a perception that the Fed is turning slightly dovish and will be a little less aggressive on its rate hikes going forward, and the Q2 earnings, which are coming in better than analysts had feared. The S&P 500 might still be down 10% for the year, but the index has gained 17% since its mid-June low, and with the macro environment appearing friendlier, investors will be hoping the change of sentiment won’t be a temporary one. Again

  • Afraid you missed the stock-market bottom? History says curb your FOMO.

    Signs of FOMO are evident in the summer stock-market rally. A strategist takes a look at what happened to investors who 'missed' the bottom in previous bear markets.

  • Seeking at Least 11% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy

    Markets fell into bear territory through the first half of the year – but we saw a summer rebound in July that has stabilized this month. Both the S&P 500 and the NASDAQ indexes have climbed back out of their bear markets, and investor sentiment, at least for now, is positive. However, at least some of the market experts are taking a much more guarded view of current conditions. Looking into the history of market downturns, Bank of America strategists see indicators that we haven’t hit bottom ye

  • 3M Faces $100 Billion in Losses From Veterans' Earplug Suits, Expert Says

    (Bloomberg) -- 3M Co. faces more than $100 billion in losses and bankruptcy because of lawsuits brought by veterans who blame their hearing problems on faulty earplugs, according to a litigation consultant hired by lawyers suing the industrial conglomerate.Most Read from BloombergSaudi Billionaire Made $500 Million Russia Bet at War Onset‘Next Generation’ Moderna Coronavirus Booster Jab Approved for Use in AdultsThese Six Cities Are Emerging as New Expat Hot SpotsAmerica’s $7 Trillion Retirement

  • Top after-hours movers: Apple, Cassava Sciences, Canoo, Digital World Acquisition Corp.

    Top trending after-hours tickers on Yahoo Finance.

  • Indian Billionaire’s Stock Holdings Worth Nearly $4 Billion in Focus After Death

    (Bloomberg) -- The death of Indian billionaire Rakesh Jhunjhunwala puts a spotlight on the nearly $4 billion worth of stocks held by the famed investor, whose trades were closely followed.Most Read from BloombergSaudi Billionaire Made $500 Million Russia Bet at War Onset‘Next Generation’ Moderna Coronavirus Booster Jab Approved for Use in AdultsWells Fargo Plans Major Retreat From Mortgage Business It Long DominatedDOJ Opposes Release of Affidavit in Trump Search, Citing ProbeSingapore’s Next Pr

  • If you really want to be rich, you need to do this, says Mark Cuban

    Recently, we came across a simple piece of money advice from billionaire entrepreneur Mark Cuban on his Maverick blog that we felt resonated in today’s money-stressed world. Indeed plenty of pros agree with him that saving money can make you, if not rich, then at least richer (and the good news is this: savings accounts are now paying far more than they did a year ago, and you can find the best rates you can get here). “The first step is you have to want to make changes,” says certified financial planner Spencer Betts of Bickling Financial Services.

  • President Biden forgives nearly $4 billion in student debt — what’s next?

    The pause on student loan repayments is ending soon, what are Biden’s options on student debt?

  • Jim Cramer Recommends Selling These 10 Stocks in August

    In this article, we discuss the 10 stocks that Jim Cramer recommends selling in August. If you want to read about some more stocks that Jim Cramer recommends selling, go directly to Jim Cramer Recommends Selling These 5 Stocks in August. Jim Cramer, the former hedge fund manager and present host of Mad Money on […]

  • Follow Warren Buffett’s Lead. Park Your Cash in This Ultra-Safe Investment.

    Investors can buy the short-term Treasury bills, now yielding as much as 3%, from the government and brokers or through funds.

  • US Futures Slide as Fed Worries Outweigh Earnings: Markets Wrap

    (Bloomberg) -- US stock-index futures fell as concerns over the Federal Reserve’s aggressive rate-hike path outweighed robust corporate earnings and China’s stimulus plans.Most Read from BloombergSaudi Billionaire Made $500 Million Russia Bet at War OnsetAmerica’s $7 Trillion Retirement Crisis Is Only Getting Worse‘Next Generation’ Moderna Coronavirus Booster Jab Approved for Use in AdultsThese Six Cities Are Emerging as New Expat Hot SpotsBill Gates and the Secret Push to Save Biden’s Climate B

  • Cineworld anticipates significant share dilution after weak admissions

    The FTSE 250 cinema operator said it is in discussions with stakeholders and is evaluating options for a potential restructuring of its balance sheet.

  • IRS's RMD Rule Change Could Make Your Roth IRA More Valuable

    The Internal Revenue Service has proposed rule changes that could significantly impact how beneficiaries will manage inherited retirement accounts. The proposed regulations, which were published last month, caught some in the financial services industry by surprise, as they offer a … Continue reading → The post The IRS May Make Your Roth IRA More Valuable With This RMD Rule Change appeared first on SmartAsset Blog.

  • Coinbase Stock: Here’s Why Cathie Wood Dumped It

    Shares of popular crypto-exchange platform Coinbase (COIN) have been under an absurd amount of selling pressure over the past year, tanking 75% from peak to trough. The negative momentum has been unforgiving to even the boldest of investors. Innovation investor Cathie Wood recently announced that she had thrown in the towel over the reported SEC probe. Undoubtedly, the SEC securities warning is more salt poured into the wounds of Coinbase's already ailing shareholders. With Cathie Wood likely se

  • Clean energy stocks are the winners of the Inflation Reduction Act

    Clean energy related stocks have been the clear winners of the Democrats' climate bill called the Inflation Reduction Act (IRA). Solar panel makers, fuel cell manufacturers and energy storage companies all stand to benefit from the measure.

  • The Company That Built Elon Musk's Tiny Home Has Now Raised Over $74 Million From Retail Investors

    Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk generated headlines last year when he announced in a tweet that he would sell almost all his physical possessions and will not own a house. Musk reportedly followed through with that plan and moved into a tiny house in Texas after disposing of all of his mansions. Recent rumors suggested that Musk’s primary residence was a prefab house manufactured by Boxabl. It turns out, however, that the $50,000 foldable house is actually being used as a guest house. Wh